Stephen H. Gillespie

Oct 31, 2024 | nature.com | Katherine Keenan |Benon B. Asiimwe |Andy Lynch |Dominique L Green |Qing Zhang |Rachel Sippy | +6 more

AbstractThe global health crisis of antibacterial resistance (ABR) poses a particular threat in low-resource settings like East Africa. Interventions for ABR typically target antibiotic use, overlooking the wider set of factors which drive vulnerability and behaviours.

Feb 28, 2024 | microbiologyresearch.org | Stephen H. Gillespie |Kerry Falconer |Peter M. Hawkey |Robert Hammond

Background. A bloodstream infection (BSI) presents a complex and serious health problem a problem that is being exacerbated by increasing antimicrobial resistance (AMR). Gap Statement. The current turnaround times (TATs) for most antimicrobial susceptibility testing (AST) methods offer results retrospective of treatment decisions and this limits the impact AST can have on antibiotic prescribing and patient care.

Feb 28, 2024 | microbiologyresearch.org | Kerry Falconer |Robert Hammond |Benjamin J. Parcell |Stephen H. Gillespie

Article metrics loading... /content/journal/jmm/10.1099/jmm.0.001812Download as PowerPoint /deliver/fulltext/jmm/73/2/jmm001812.html?itemId=/content/journal/jmm/10.1099/jmm.0.001812&mimeType=html&fmt=ahah References O’Neill J.

Oct 9, 2023 | frontiersin.org | Jean-Marie Boeynaems |Douglas Slain |Stephen H. Gillespie

1 IntroductionOver the past few decades, public reporting of health providers’ performance (PRHPP) has been increasingly used for the purpose of improving the quality of patient care (Marshall et al., 2000). It started in the United States in the 1980s (Hannan et al., 1994) and has since been adopted by many other developed countries (Hibbard et al., 2003; Marshall et al., 2003).

Sep 20, 2023 | frontiersin.org | Iroh Tam |Malawi-Liverpool Wellcome Programme |Orthopaedic Surgery |Stephen H. Gillespie

BackgroundAntimicrobial resistance (AMR) has reached alarming levels globally, and is estimated to cause 4.95 million deaths globally, with the highest rates being in sub-Saharan Africa (Antimicrobial Resistance C, 2022). Addressing AMR has been most problematic in low resource settings, which lack infrastructure, diagnostic capacity, and robust data management systems, among other factors.